Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

MedComm, 2026

Genetic Regulation of DNA Methylation and Its Mediating Role in Blood Pressure: A Genome‐Wide Twin Study

Hong X., Li M., Cao W. et al.

Advanced Science, 2026

Proteogenomic Profiling of Idiopathic Pulmonary Arterial Hypertension Identifies Sex‐Differential Proteins and Candidate Therapeutic Targets

Lin X., Zhang Y., Pu Y. et al.

BMC Psychiatry, 2026

Olink proteomics reveals immuno-inflammatory profile changes and potential regulatory mechanisms of non-suicidal self-injury behavior associated with depression in adolescent

Xu H., Liang X., Xia Y. et al.

European Journal of Preventive Cardiology, 2026

Metabolic obesity phenotypes and degenerative valvular heart disease: a cohort study

Yan Z., Bing S., Gong Y. et al.

Med, 2026

An adult proteomic signature associated with very low birth weight and chronic disease risk

Huang C., Seong D., Reiss J. et al.

Cell Systems, 2026

Plasma proteins are integral to cross-tissue gene regulatory networks implicated in cardiometabolic disorders and coronary artery disease

Bankier S., Talukdar H., Khan M. et al.

Gut Microbes, 2026

Gut microbiota functional remodeling and butyrate depletion amplify anti-Ro/La antibody-driven type I interferon activation in neonatal lupus

Sun W., Li Y., Liu X. et al.

Nature Medicine, 2026

Sex-specific biological aging clocks across organs and omics

Song Z., Feng D., Rahman N. et al.

Scientific Reports, 2026

Plasma five-protein risk score for prognostic stratification in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Goh M., Song B., Kang W. et al.

Translational Psychiatry, 2026

The interplay of PICALM with APOE ε4 on Alzheimer’s disease: clues from two longitudinal cohorts and proteomic studies

Luo X., Gao L., Huang L. et al.

Scientific Reports, 2026

Genetic variation in MYLIP is associated with lipid, thyroid, liver, and hematologic traits in women

Klevjer M., Nordeidet A., Kararigas G. et al.

GeroScience, 2026

Common and distinct plasma proteomic signature of aerobic and motor physical activity interventions and their link to episodic memory

Mury P., Jaulgey K., Vrinceanu T. et al.

Nature Communications, 2026

Multimodal data-driven clustering analysis of heart failure patients identifies two distinct patterns of heart failure with preserved ejection fraction: Results from the PACIFIC-PRESERVED study

Hulot J., Hervé P., Girerd N. et al.

Alzheimer's & Dementia, 2026

Genetic and molecular evidence linking CTSH to Alzheimer's disease pathophysiology

Picard C., Aumont‐Rodrigue G., Sarty I. et al.

ACR Open Rheumatology, 2026

Impact of Selective Tyrosine Kinase 2 Inhibition With Zasocitinib ( TAK ‐279) on Molecular Pathways and Correlated Clinical Response in Patients With Active Psoriatic Arthritis

Choudhury A., Cheng J., Tang J. et al.

Frontiers in Immunology, 2026

Multidimensional neuropsychological heterogeneity in obstructive sleep apnea: deep clinical phenotyping in a single-center cohort, population proteomic context, and depressive-burden risk stratification

Wang X., Jiang Y., Yu L. et al.

Frontiers in Psychiatry, 2026

A discovery plasma proteome signature in military personnel with chronic PTSD symptoms

Lim A., Robey C., Kenney K. et al.

Brain, Behavior, and Immunity, 2026

DREADDs-Gi mediated inhibition of myeloid cells leads to anti-inflammatory signalling, shrinkage of microglia and acute heart failure in Cx3cr1Cre mice

Holde F., Pedersen T., Frandsen S. et al.

Clinical Proteomics, 2026

Pre-surgical immune-proteomic profiles in serum identify inflamed and suppressed immune states associated with biochemical recurrence and PSA persistence in prostate cancer

Desiati I., Bozorgpana S., Ramberg H. et al.

Journal of Neurology, 2026

Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington’s disease progression

Grétarsdóttir H., Cunningham J., Rasmusson A. et al.

4555 publications